Metastatic disease is a leading cause of cancer-related deaths, and it is unclear whether organ-specific tolerance mechanisms are involved in cancer outcomes. I mainly focus on investigating the mechanisms that underlie metastatic tumor growth in different organs and identifying potential molecular targets for both preventative and treatment interventions.
